CN102798720B - Immune chromatography test paper for quantitative determination of clenbuterol based on up-conversion fluorescent nanoparticle label and preparation method thereof - Google Patents
Immune chromatography test paper for quantitative determination of clenbuterol based on up-conversion fluorescent nanoparticle label and preparation method thereof Download PDFInfo
- Publication number
- CN102798720B CN102798720B CN201210281872.0A CN201210281872A CN102798720B CN 102798720 B CN102798720 B CN 102798720B CN 201210281872 A CN201210281872 A CN 201210281872A CN 102798720 B CN102798720 B CN 102798720B
- Authority
- CN
- China
- Prior art keywords
- antibody
- nano particle
- nayf
- solution
- trace
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 87
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 67
- 238000002360 preparation method Methods 0.000 title claims abstract description 44
- 238000006243 chemical reaction Methods 0.000 title claims abstract description 36
- 229960001117 clenbuterol Drugs 0.000 title claims abstract description 10
- STJMRWALKKWQGH-UHFFFAOYSA-N clenbuterol Chemical compound CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 STJMRWALKKWQGH-UHFFFAOYSA-N 0.000 title claims abstract description 10
- 238000004587 chromatography analysis Methods 0.000 title abstract description 6
- 229920002678 cellulose Polymers 0.000 claims abstract description 54
- 239000001913 cellulose Substances 0.000 claims abstract description 54
- 238000001514 detection method Methods 0.000 claims abstract description 36
- 239000000463 material Substances 0.000 claims abstract description 23
- 230000002745 absorbent Effects 0.000 claims abstract description 19
- 239000002250 absorbent Substances 0.000 claims abstract description 19
- 241000283707 Capra Species 0.000 claims abstract description 14
- 230000008878 coupling Effects 0.000 claims abstract description 12
- 238000010168 coupling process Methods 0.000 claims abstract description 12
- 238000005859 coupling reaction Methods 0.000 claims abstract description 12
- 102000014914 Carrier Proteins Human genes 0.000 claims abstract description 10
- 108010078791 Carrier Proteins Proteins 0.000 claims abstract description 10
- 239000012460 protein solution Substances 0.000 claims abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- 239000000243 solution Substances 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 31
- 239000000835 fiber Substances 0.000 claims description 30
- 239000012528 membrane Substances 0.000 claims description 29
- 238000005406 washing Methods 0.000 claims description 18
- 238000001556 precipitation Methods 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 239000007853 buffer solution Substances 0.000 claims description 15
- 239000000376 reactant Substances 0.000 claims description 15
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 13
- 235000019441 ethanol Nutrition 0.000 claims description 13
- 229920000742 Cotton Polymers 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 239000003365 glass fiber Substances 0.000 claims description 12
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 11
- 238000005576 amination reaction Methods 0.000 claims description 11
- 239000006228 supernatant Substances 0.000 claims description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 239000004677 Nylon Substances 0.000 claims description 8
- 238000013019 agitation Methods 0.000 claims description 8
- 229920001778 nylon Polymers 0.000 claims description 8
- 229920002981 polyvinylidene fluoride Polymers 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 239000000020 Nitrocellulose Substances 0.000 claims description 6
- 239000002033 PVDF binder Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 229920001220 nitrocellulos Polymers 0.000 claims description 6
- 229920006267 polyester film Polymers 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 239000007787 solid Substances 0.000 claims description 6
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 claims description 5
- 239000011259 mixed solution Substances 0.000 claims description 5
- 238000004321 preservation Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000002604 ultrasonography Methods 0.000 claims description 5
- 229910052691 Erbium Inorganic materials 0.000 claims description 4
- 101000609762 Gallus gallus Ovalbumin Proteins 0.000 claims description 4
- 229910052769 Ytterbium Inorganic materials 0.000 claims description 4
- 238000000975 co-precipitation Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 108060003552 hemocyanin Proteins 0.000 claims description 4
- 238000001027 hydrothermal synthesis Methods 0.000 claims description 4
- 239000011159 matrix material Substances 0.000 claims description 4
- 230000001681 protective effect Effects 0.000 claims description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000005642 Oleic acid Substances 0.000 claims description 3
- 230000032683 aging Effects 0.000 claims description 3
- 239000007767 bonding agent Substances 0.000 claims description 3
- 229940098773 bovine serum albumin Drugs 0.000 claims description 3
- 238000001354 calcination Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 238000010521 absorption reaction Methods 0.000 claims description 2
- 239000007850 fluorescent dye Substances 0.000 claims description 2
- 238000001215 fluorescent labelling Methods 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000001179 sorption measurement Methods 0.000 abstract 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 41
- 239000000523 sample Substances 0.000 description 39
- 210000002966 serum Anatomy 0.000 description 10
- 239000000427 antigen Substances 0.000 description 8
- 102000036639 antigens Human genes 0.000 description 8
- 108091007433 antigens Proteins 0.000 description 8
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 229960001399 clenbuterol hydrochloride Drugs 0.000 description 5
- OPXKTCUYRHXSBK-UHFFFAOYSA-N clenbuterol hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)C1=CC(Cl)=C(N)C(Cl)=C1 OPXKTCUYRHXSBK-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000004090 dissolution Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002086 nanomaterial Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 238000002965 ELISA Methods 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000000521 hyperimmunizing effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000003053 immunization Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 235000020997 lean meat Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- BUXRLJCGHZZYNE-UHFFFAOYSA-N 2-amino-5-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzonitrile Chemical compound CC(C)NCC(O)C1=CC=C(N)C(C#N)=C1 BUXRLJCGHZZYNE-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 229930193140 Neomycin Natural products 0.000 description 2
- TURHTASYUMWZCC-UHFFFAOYSA-N Olaquindox [BAN:INN] Chemical compound C1=CC=C2N([O-])C(C)=C(C(=O)NCCO)[N+](=O)C2=C1 TURHTASYUMWZCC-UHFFFAOYSA-N 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 2
- 229940097572 chloromycetin Drugs 0.000 description 2
- 229950010971 cimaterol Drugs 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 229960004927 neomycin Drugs 0.000 description 2
- 229950010210 olaquindox Drugs 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229940092253 ovalbumin Drugs 0.000 description 2
- 229960000321 oxolinic acid Drugs 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- YJQZYXCXBBCEAQ-UHFFFAOYSA-N ractopamine Chemical compound C=1C=C(O)C=CC=1C(O)CNC(C)CCC1=CC=C(O)C=C1 YJQZYXCXBBCEAQ-UHFFFAOYSA-N 0.000 description 2
- 229940074095 ractopamine Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000011895 specific detection Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004306 sulfadiazine Drugs 0.000 description 2
- 229950003874 sulfamonomethoxine Drugs 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000004130 lipolysis Effects 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000003760 magnetic stirring Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000005064 physico chemical analysis method Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- -1 sulfaminic acid ammonium salt Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
The invention discloses an immune chromatography test paper strip for the quantitative determination of clenbuterol based on up-conversion fluorescent nanoparticle label and a preparation method thereof. The test paper strip comprises a supporting layer, an adsorption layer, and a protection layer, wherein the adsorption layer comprises an adsorption fibrous layer, a fluorescent antibody fibrous layer, a cellulose film and an absorbent material layer at the handle end, the cellulose film is provided with detection blots printed by using a CL coupling carrier protein solution and control blots printed by using goat anti-mouse IgG antibodies, and the fluorescent antibody is an NaYF4:Yb:Er nanoparticle labelled CL monoclonal antibody or polyclonal antibody. According to the invention, the application of immune chromatography based on the up-conversion fluorescent nanoparticle label in the quantitative determination of CL residues is realized, so that the detection of the CL residues has no background interference; and the test paper strip has the advantages of strong specificity, high sensitivity, simple, and accurate detection, low cost, wide application scope, and easiness in popularization and application.
Description
Technical field
The present invention relates to a kind of immune chromatography test paper, particularly relate to more than one conversion luminescent materials as biomarker for quantitative immuno-chromatographic test paper strip detecting residual of kelengtelu and preparation method thereof.
background technology
Clenbuterol (Clenbuterol, CL), is commonly called as " clenbuterol hydrochloride ", and clenobuterol hydrochloride is its hydrochloride, and have and promote muscle development and lipolysis effect, Clenbuterol can improve the carcass lean meat percentage of meat animals.Because consumer is to the special preferences of lean meat, the pig that lean meat output capacity is high can be fetched a good price, and adds " clenbuterol hydrochloride " and brings extra returns to raiser.Therefore, ordering about by undue profits, raiser is everlasting cultivating link interpolation " clenbuterol hydrochloride " in animal feed.
But Clenbuterol is a kind of selectivity β
2-adrenoceptor agonists, spinoff is very big, can cause the infringement of cardiovascular system and serious nervous symptoms when intake is larger.After people have eaten the pluck and meat containing residual of kelengtelu, acute or chronic kreotoxism can be caused, the health of harm consumer.Neither one state approval " Clenbuterol " can be used in animal productiong so far, but there is the situation of illegal use for a long time always, causes the event of serious food poisoning not rarely seen all over the world.Also there is " clenbuterol hydrochloride " poisoning in the multiple city of China in recent years, greatly threaten the physical and mental health of consumer.
The method detected for residual of kelengtelu is more, mainly contains (1) physico-chemical analysis method, as high pressure liquid chromatograph, gas chromatography, thin-layer chromatography, electrophoresis etc.; (2) immunoassay, as radioimmunology, enzyme linked immunosorbent assay etc.; (3) bioassay method, as microbiological assay, radioreceptor assay etc.But these methods need expensive instrument and equipment, need skilled professional's operation, operating process is complicated, and detection time is longer, limits its range of application, is difficult to apply in actual production.
Immune test paper method has sxemiquantitative and certain quantitation capabilities, can provide the preliminary information of determinand, and this method is highly sensitive, and analytic process is simple, and the examination being used as " clenbuterol hydrochloride " has unique advantage, is the detection technique needing to first develop.Up-conversion fluorescence technology (UPT), that one has high sensitivity, new bio detection technique based on upper converting phosphor body (UCP), UCP has unique physical arrangement and optical characteristics, it is a kind of phosphor of complete inertia, after finishing with activation, can be used as novel markings thing and apply in field of biological detection.Through retrieval, for detecting Pesticide, the UCP immune chromatography test paper of residue of veterinary drug has no report, although colloid gold test paper is applied wider in this regard, but it can not accomplish quantitative detection, as the research of more responsive, stable, flexible, safe UPT-LF, that the strong of colloid gold immune detection technique supplements, the research and exploitation of this aspect in urgent need of strengthening.
Summary of the invention
The technical problem to be solved in the present invention: the deficiency existed for prior art, provide a kind of special, sensitive, quick, easy, can quantitative immuno-chromatographic test paper strip detecting residual of kelengtelu and preparation method thereof.
Technical scheme of the present invention:
A kind of immuno-chromatographic test paper strip of the detection Clenbuterol based on upper conversion fluorescent nano particle mark, bottom is supporting layer, middle layer is adsorbed layer, protective seam is fixed on adsorbed layer, adsorbed layer is followed successively by the absorbent material layer of adsorbing fiber layer, fluorescence antibody fibrage, cellulose rete and handle end from test lead, stealth cellulose rete is provided with the carrier protein solution of coupling CL is printed detects trace, is also provided with the stealth contrast trace printed with goat anti-mouse igg, rabbit anti-mouse IgG or goat anti-rabbit igg antibody solution; Described fluorescence antibody fibrage adopts the glass fibre cotton of absorption fluorescence antibody to make, and fluorescence antibody adopts NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody.
Described NaYF
4: Yb:Er nano particle is with NaYF
4for matrix, Yb
3+for sensitizer, the diameter formed by Yb and Er codope is the nano particle of 50-200nm.
Described NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody are prepared by following methods, and concrete steps are:
(1) surface siliconization of fluorescent nano particle
By NaYF
4: it is in the ethanolic solution of 10% that Yb:Er fluorescent nano particle is dispersed in mass concentration, under agitation adds 5ml strong aqua, and reaction 10min, then adds 2ml tetraethyl orthosilicate, room temperature reaction 3h; The centrifugal 5min of 6000rpm, disperses with ethanol after washing;
(2) surface amination of fluorescent nano particle
The fluorescent nano particle of surface siliconization is added in the mixed solution of methyl alcohol that volume ratio is 3:5, acetone, disperse through ultrasound wave, add N-(2-the aminoethyl)-3-aminopropyl trimethoxysilane of 5 μ l, 70 DEG C of water-bath 1h, the centrifugal 5min of 6000rpm, the precipitation ethanol obtained is washed, dry;
(3) mark of CL antibody
By the NaYF that surface is modified through amination
4: Yb:Er nano particle PBS buffer solution disperses, add the glutaraldehyde solution of mass concentration 25% wherein, room temperature reaction 3 hours, centrifugally wash away unnecessary glutaraldehyde, then be dispersed in PBS buffer solution by reactant liquor, add monoclonal antibody or the polyclonal antibody of CL, 4 DEG C are reacted 3 hours, through centrifuge washing, namely obtain NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody, be placed in PBS buffer solution, 4 DEG C of preservations.
Described adsorbing fiber layer glass fibre cotton, nylon membrane, PVDF membrane or polyester film; Absorbent material layer absorbent filter, the supporting layer toughness material do not absorbed water; Cellulose rete nitrocellulose filter, pure cellulose film or carboxylated cellulose film;
the carrier protein of coupling CL is bovine serum albumin(BSA), chicken ovalbumin or hemocyanin.
Described stealth detect trace and stealthy contrast trace be arranged in parallel "
︱ ︱" orthoscopic trace, or be " 10 " font arrangement trace, or be " ┬ ┬ " font arrangement trace, or be " ┴ ┴ " font arrangement trace, or be " ├ ├ " font arrangement trace, or be " ┤ ┤ " font arrangement trace.
Described adsorbing fiber layer, fluorescence antibody fibrage and absorbent material layer are coated with diaphragm; the diaphragm that adsorbing fiber layer is corresponding with fluorescence antibody fibrage intersection is printed with sample mark line, this mark line deflection adsorbing fiber layer side 0.3-0.7cm.
Described NaYF4:Yb:Er nano particle adopts coprecipitation preparation, and concrete grammar is as follows:
Get the Y (NO that concentration is 0.2mol/L respectively
3)
3yb (the NO of 20ml, 0.2mol/L
3)
3er (the NO of 2ml, 0.2mol/L
3)
3the EDTA-Na21ml of 0.5ml, 1mol/L, adds in flask, and 50 DEG C of oil bath stirring reaction 1h, obtain reactant liquor A;
Get the NaF solution of 50ml, 1mol/L, add in polytetrafluoroethylcontainer container, under 50 DEG C of stirred in water bath, reactant liquor A is poured in NaF solution, reaction 1min; The centrifugal 5min of 6000rpm, abandoning supernatant must precipitate; Add water in precipitation, ultrasonic washing 3 times, the centrifugal 5min of 7000rpm; Again by precipitation absolute ethyl alcohol ultrasonic washing 2 times, the centrifugal 5min of 10000rpm, is placed in 80 DEG C of baking oven dried overnight by the solid obtained; Dried solid is put into muffle furnace, in 500 DEG C of calcining 5h, namely obtains NaYF
4: Yb:Er fluorescent nano particle.
Described NaYF
4: Yb:Er nano particle also can adopt hydrothermal synthesis method to prepare, and concrete grammar is as follows:
Get the Y (NO that concentration is 0.2mol/L respectively
3)
34ml, Yb (NO
3)
30.5ml, Er (NO
3)
30.1ml, EDTA-Na4ml, mix and fully react, and obtains reactant liquor A; Take NaOH 0.7g, join in the mixed liquor of 8ml oleic acid and 12ml ethanol, mixing, the under agitation slow NaF solution injecting 10mL, 1mol/L in mixed liquor, after filling, continue to be stirred to solution and to be translucent shape; Reactant liquor A is poured in described solution, mixes, ageing 20-30min; Then potpourri is transferred in polytetrafluoroethylcontainer container, 130-150 DEG C of oil bath reaction 12-18h, the product obtained after filtration, washing, dry, namely obtain NaYF
4: Yb:Er fluorescent nano particle.
The preparation method of described immuno-chromatographic test paper strip, is characterized in that: the method comprises the following steps:
(1) preparation of CL monoclonal antibody or polyclonal antibody;
(2) preparation of fluorescence antibody: first prepare NaYF
4: Yb:Er fluorescent material, described fluorescent material is with NaYF
4for matrix, Yb
3+for sensitizer, formed the nano particle of diameter 50-200nm by Yb and Er codope; Then CL monoclonal antibody or polyclonal antibody are carried out fluorescence labeling;
(3) preparation of adsorbing fiber layer: adsorbing fiber layer glass fibre cotton, nylon membrane, PVDF membrane or polyester film are made;
(4) preparation of cellulose rete: cellulose rete nitrocellulose filter, pure cellulose film or carboxylated cellulose film, with point sample instrument diverse location specking detection trace and contrast trace respectively on cellulose membrane, dries;
(5) assembling of test strips: adsorbing fiber layer, fluorescence antibody fibrage, cellulose rete, absorbent material layer are attached to from right to left successively and scribble on the supporting layer of bonding agent, successively supporting layer, adsorbed layer and protective seam are assembled into test strips.
Described fluorescently-labeled concrete steps are as follows:
(1) surface siliconization of fluorescent nano particle
By NaYF
4: it is in the ethanolic solution of 10% that Yb:Er fluorescent nano particle is dispersed in mass concentration, under agitation adds 5ml strong aqua, and reaction 10min, then adds 2ml tetraethyl orthosilicate, room temperature reaction 3h; The centrifugal 5min of 6000rpm, disperses with ethanol after washing;
(2) surface amination of fluorescent nano particle
The fluorescent nano particle of surface siliconization is added in the mixed solution of methyl alcohol that volume ratio is 3:5, acetone, disperse through ultrasound wave, add N-(2-the aminoethyl)-3-aminopropyl trimethoxysilane of 5 μ l, 70 DEG C of water-bath 1h, the centrifugal 5min of 6000rpm, the precipitation ethanol obtained is washed, dry;
(3) mark of CL antibody
By the NaYF that surface is modified through amination
4: Yb:Er nano particle PBS buffer solution disperses, add the glutaraldehyde solution of mass concentration 25% wherein, room temperature reaction 3 hours, centrifugally wash away unnecessary glutaraldehyde, then be dispersed in PBS buffer solution by reactant liquor, add monoclonal antibody or the polyclonal antibody of CL, 4 DEG C are reacted 3 hours, through centrifuge washing, namely obtain NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody, be placed in PBS buffer solution, 4 DEG C of preservations.
positive beneficial effect of the present invention:
(1) high specificity, highly sensitive.Test strips of the present invention is with upconversion fluorescence nano material NaYF
4: Yb:Er marks based on CL antibody and makes, can under infrared light direct observed result, due to NaYF
4: the outstanding optical characteristics of Yb:Er nano particle, make the detection of CL eliminate the interference of bias light, sensitivity improves greatly, minimumly a trace residue for gram level detected.
(2) stability is high, and dirigibility is good.In test strips, the luminescence phenomenon of UCP is because the pure physical process of its inside configuration produces, and completely avoid Autonomous test sample etches and the luminous cancellation caused that self decays; What UCP had the diversified characteristic spectrum (absorption spectrum and emission spectrum) of independent assortment can be applicable to multiple analysis.
(3) security is good.Upconversion fluorescence nano material in test strips has the feature of inorganic inert, infrared ray excited, VISIBLE LIGHT EMISSION, makes detection based on UCP for tester, detected product and environment all without any harm.
(4) easy, quick.Test strips can carry out direct-detection to whole blood, urine, saliva, tissue homogenate etc., need not carry out the pre-service of sample.Use test strips of the present invention directly can read value by phosphor reader, realize quantitatively detecting, can execute-in-place.As long as test strips to be inserted test sample 10 ~ 20 second, in 5 minutes, testing result can be judged.
(5) result display is vivid, directly perceived, accurate.Test strips of the present invention with show redness "
︱" and "
︱ ︱" (or " ten ", " ┬ ", " ┴ ", " ├ ", " ┤ ") trace as the positive detected and negative marker, namely show on cellulose membrane redness "
︱" trace, represent in test sample containing CL; Show two redness "
︱ ︱" trace, represent in test sample not containing CL.This result can with the naked eye directly be observed, and it is vivid, directly perceived, accurate, simple and clear to judge, not easily occurs the artificially erroneous judgement such as false positive and false negative.
(6) applied widely, easy to utilize.Present invention achieves the application of immunochromatography technique in quantitative detection CL remains based on upconversion fluorescence nano material mark, the residual detection of CL is disturbed without background; This test strips is easy and simple to handle, can meet the needs of different levels personnel, comprises specialty chemical examination, customs quarantine control, health quarantine, quality monitoring, livestock products processing, raiser and consumer individual etc.The present invention ensuring food safety, Protection of consumer healthy in be extremely important, obvious economic benefit and social benefit will be had.
(7), when prepared by test strips of the present invention, fluorescence antibody adopts NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody, labeling process is simple, only need by amidized NaYF
4: Yb:Er nano particle is directly connected with antibody, avoid the tedious steps that collaurum-antibody is connected, and by controlling the Conjugate ratio of volumetric molar concentration adjustment fluorescent nano particle and antibody, thus can effectively improve the sensitivity based on the Sidestream chromatography immune test paper of upconversion fluorescence nano material.
Accompanying drawing explanation
Fig. 1 is the structural representation of immuno-chromatographic test paper strip of the present invention;
Fig. 2 is the plan structure schematic diagram of immuno-chromatographic test paper strip of the present invention;
Fig. 3 is the regression curve of immuno-chromatographic test paper strip of the present invention to CL.
Embodiment
Test strips preparation process of the present invention comprises: the preparation of the preparation of CL monoclonal or polyclonal antibody, the preparation of fluorescence antibody fibrage (pad), adsorbing fiber layer (sample pad), the step such as the preparation of cellulose rete (analyzing film) and the assembling of test strips.
1, the preparation of CL monoclonal antibody or polyclonal antibody
The preparation of monoclonal antibody: comprise the immunogenic preparation of CL, immune animal (mouse), Fusion of Cells, the screening of monoclonal antibody, the preparation of monoclonal antibody; The preparation of polyclonal antibody: comprise the immunogenic preparation of CL, immune animal (rabbit), the screening of polyclonal antibody, the preparation of polyclonal antibody.
(1) preparation of CL artificial antigen:
100 mg CL standard items are dissolved in the hydrochloric acid of 10mL, 1mol/L, slowly drip the NaNO of 30%
2solution, by starch KI detection paper, be added to when KI test paper is brown purple and stop dripping, stirring reaction 45 min, drips the sulfaminic acid ammonium salt solution of 5%, with its reaction end of starch KI detection paper.The CL solution of azo slowly dripped the PBS(pH7.4 in being dissolved with 300 mg BSA with dropper) in, and by the NaOH solution adjust ph to 9.0 of 1 mol/L, after 4 DEG C of lucifuges react 24 h, 4 DEG C of dialysis 48 h, packing ,-20 DEG C save backup.In like manner prepare coating antigen.
(2) preparation of CL monoclonal antibody:
With obtained CL artificial antigen with 50 μ g ~ 100 μ g/ consumption immunity BALB/c mouse in 6 ~ 8 week age only 3 ~ 4 times, each immunization interval 3 ~ 5 weeks, determine antibody titer meet the requirements after superpower immunity, 3 ~ 4 days afterwards by under immune mouse socket of the eye hole blood sampling, be separated positive serum; De-neck is lethal, and the alcohol-pickled mouse 5 ~ 10min with 75% sterilizes body surface, asepticly gets its spleen, is shredded by spleen and grinds, filtering, the centrifugal 10min of 1000rpm through 120 order nylon gauzes, collection splenocyte.By 1 × 10
8splenocyte mix in the ratio of 10:1 with NS0 myeloma cell, the centrifugal 10min of 1000rpm, abandons supernatant, and cell precipitation thing slowly adds the PEG4000 effect 1min of 0.7 ~ 1.0mL 50% in 37 DEG C of water-baths, then serum-free 1640 nutrient culture media 15mL is slowly added, to stop the effect of PEG; 37 DEG C of water-bath 5 ~ 10 min, 1000rpm is centrifugal, and 10min abandons supernatant, is resuspended in HAT Selective agar medium by cell precipitation thing, and adds 96 porocytes cultivation plate hole (100 μ L/ hole, μ L ~ 200), is placed in 37 DEG C, 5%CO
2cultivate in incubator.Cultivate 10 ~ 14 days, carry out positive hole sizer choosing with indirect elisa method, selection strong positive, the hole that inhibiting rate is high, Growth of Cells is vigorous carry out 3 limited dilution clonings, then expand cultivation, set up hybridoma cell strain.The monoclonal antibody of prepared hybridoma secretion can be reacted with CL specifically, and affinity constant reaches 10
10~ 10
12, light chain subtype is κ or λ, and heavy chain subgroup is IgG
1, IgG
2a, IgG
2b, IgG
3, for the monoclonal antibody of CL specific epitope, for the preparation of fluorescence antibody glass fibre cotton.
(3) preparation of CL polyclonal antibody:
With obtained CL artificial antigen immunize New Zealand white rabbits, immunizing dose is 200 μ g ~ 500 μ g/ time, and dorsal sc divides 4 ~ 6 injections.Head exempts from, and dissolves CL artificial antigen, mix with equivalent FCA with aseptic PBS, fully emulsified; Booster immunization, dissolves CL carrier protein couplet thing with aseptic PBS, mix with equivalent FIA, fully emulsified, within 2 ~ 3 weeks, carries out, continuous immunity 4 ~ 5 times, every minor tick 2 ~ 3 weeks after head exempts from, last immune latter 10 ~ 15 days, surveys it surely tire and reach 10 with ELISA method
5time above, blood sampling is separated and collected hyper-immune serum also.IgG antibody is extracted with saturated ammonium sulfate salting out method, namely get 1 portion of hyper-immune serum and add 2 parts of PBS(pH7.2) mixing, add the mixing of equal-volume saturated ammonium sulfate solution, put 4 DEG C of refrigerator 12h, 4 DEG C, the centrifugal 15min of 2500rpm, abandon supernatant, again with appropriate PBS(pH7.2) dissolution precipitation, add saturated ammonium sulfate solution to final concentration 33%, put 4 DEG C of refrigerator 2h, 4 DEG C, the centrifugal 15min of 2500rpm, abandon supernatant, with appropriate PBS(pH7.2) dissolution precipitation, put 4 DEG C of interior PBS(pH7.2 of refrigerator) dialyse 48 ~ 72h, liquid is changed for several times in centre, 4 DEG C, the centrifugal 15min of 12000rpm, collect supernatant, obtain the anti-CL polyclonal antibody of purifying,-20 DEG C frozen, for the preparation of fluorescence antibody glass fibre cotton.
2, the preparation of fluorescence antibody fibrage (pad)
The fibrolaminar preparation of fluorescence antibody, first needs to prepare NaYF
4: Yb:Er nano particle, then with the NaYF of preparation
4: Yb:Er nanoparticle label CL antibody.
(1) NaYF
4: the preparation of Yb:Er nano particle, can adopt coprecipitation or hydrothermal synthesis method.
A. coprecipitation
Get the Y (NO that concentration is 0.2mol/L respectively
3)
3yb (the NO of 20ml, 0.2mol/L
3)
3er (the NO of 2ml, 0.2mol/L
3)
3the EDTA-Na21ml of 0.5ml, 1mol/L, adds in 100ml flask, and 50 DEG C of oil bath stirring reaction 1h, obtain reactant liquor A;
Get the NaF aqueous solution of 50ml, 1mol/L, add in polytetrafluoroethylcontainer container, under magnetic agitation, A liquid is poured in NaF aqueous solution in 50 DEG C of water-baths, water-bath 1min; The centrifugal 5min of 6000rpm, abandoning supernatant must precipitate, and adds water in precipitation, ultrasonic washing 3 times, the centrifugal 5min of 7000rpm; With absolute ethyl alcohol ultrasonic washing 2 times, the centrifugal 5min of 10000rpm, is placed in 80 DEG C of baking oven dried overnight by the solid obtained; Dried solid is put into muffle furnace, in 500 DEG C of calcining 5h, namely obtains NaYF
4: Yb:Er fluorescent nano particle.
B. hydrothermal synthesis method
Get the Y (NO that concentration is 0.2mol/L respectively
3)
34ml, Yb (NO
3)
30.5ml, Er (NO
3)
30.1ml, EDTA-Na4ml, mix and after abundant reaction, obtain reactant liquor A;
Take NaOH 0.7g, join in the mixed liquor of 8ml oleic acid and 12ml ethanol and mix, under agitation the slow NaF solution injecting 10mL, 1mol/L in mixed liquor, after filling, continue to stir, to be translucent shape to solution; Reactant liquor A is poured in described solution, mixes, ageing 20min; Then potpourri is transferred in polytetrafluoroethylcontainer container, 130 DEG C of oil baths reaction 12h, the product obtained after filtration, washing, dry, namely obtain NaYF
4: Yb:Er fluorescent nano particle.
(2) NaYF
4: Yb:Er nanoparticle label CL antibody
Labeling process comprises the following steps: NaYF
4: the surface siliconization of Yb:Er nano particle, NaYF
4: the surface amination of Yb:Er nano particle, NaYF
4: the coupling of Yb:Er nano particle and CL antibody.
A. NaYF
4: the surface siliconization of Yb:Er fluorescent nano particle
By NaYF
4: Yb:Er fluorescent nano particle is dispersed in the ethanol water of mass concentration 10%, adds 5ml strong aqua (concentration 28%) under magnetic stirring, and reaction 10min, then adds 2ml tetraethyl orthosilicate, room temperature reaction 3h; The centrifugal 5min of 6000rpm, washes 3 times, finally disperses with ethanol;
B. NaYF
4: the surface amination of Yb:Er fluorescent nano particle
The fluorescent nano particle of surface siliconization is added in the mixed solution of methyl alcohol that volume ratio is 3:5, acetone, disperse through ultrasound wave, add APTSA(N-(2-the aminoethyl)-3-aminopropyl trimethoxysilane of 5ul), 70 DEG C of water-bath 1h, the centrifugal 5min of 6000rpm, the precipitation ethanol obtained is washed 3 times, dry, preserve;
C. the mark (glutaraldehyde method) of CL antibody
By the NaYF that surface is modified through amination
4: the PBS buffer solution dispersion of Yb:Er nano particle pH=7.4, add the glutaraldehyde of mass concentration 25% wherein, room temperature reaction 3 hours, centrifugally wash away unnecessary glutaraldehyde, then be dispersed in the PBS buffer solution of pH=7.4, then add monoclonal antibody or the polyclonal antibody of CL wherein, 4 DEG C are reacted 3 hours, centrifuge washing for several times, namely obtains NaYF again
4: the antibody coupling matter of Yb:Er-CL, with 4 DEG C, the PBS buffer solution preservation of pH=7.4.
3, the preparation of adsorbing fiber layer (sample pad)
Prepared by test lead adsorbing fiber layer glass fibre cotton, nylon membrane, polyvinylidene fluoride pvdf membrane or polyester film, fibrous material is cut into the band of wide 1.5cm specification, puts it in sample pad confining liquid and soak 30min, in 37 DEG C of oven dry, for subsequent use.
4, the preparation of cellulose rete (analyzing film)
Cellulose rete nitrocellulose filter, pure cellulose film or carboxylated cellulose film, cut into the band of wide 1.5cm specification, with point sample instrument diverse location specking CL antigen and goat anti-mouse igg antibody (or rabbit anti-mouse IgG, goat anti-rabbit igg antibody) respectively on cellulose membrane, make stealthy detection trace band and contrast trace band, in 37 DEG C of dry for standby.
Wherein goat-anti or rabbit anti-mouse IgG(or goat anti-rabbit igg) preparation method of antibody is as follows:
CL negative mice serum IgG (or negative rabbit anteserum IgG) is extracted with saturated ammonium sulfate, get 1 part of mice serum (or rabbit anteserum) and add 2 parts of PBS(pH7.2) mixing, add the mixing of equal-volume saturated ammonium sulfate solution, put 4 DEG C of refrigerator 12h, 4 DEG C, the centrifugal 15min of 2500rpm, abandon supernatant; Again with appropriate PBS(pH7.2) dissolution precipitation, add saturated ammonium sulfate solution to final concentration 33%, put 4 DEG C of refrigerator 2h, 4 DEG C, the centrifugal 15min of 2500rpm, abandon supernatant; With appropriate PBS(pH7.2) dissolution precipitation, put in 4 DEG C of refrigerators, with PBS(pH7.2) dialyse 48h, liquid is changed 3 times in centre, 4 DEG C, the centrifugal 15min of 12000rpm, collects supernatant, measures its protein concentration with ultraviolet spectrophotometer; With mice serum (or rabbit anteserum) IgG of 50 μ g ~ 100 μ g/kg body weight through the healthy goat of subcutaneous and intramuscular injection or rabbit 3 ~ 4 times, final injection is after 10 days, with ELISA measure its serum titer reach more than 1:2000 time, heart or arterial blood drawing, separated and collected hyper-immune serum, goat-anti or rabbit anti-mouse IgG(or goat anti-rabbit igg is extracted with saturated ammonium sulfate) antibody (method is identical with extracting mice serum IgG, no longer repeats), the preparation of trace is contrasted for CL test strip.
5, the assembling of immuno-chromatographic test paper strip
Adsorbing fiber layer (sample pad), fluorescence antibody fibrage (pad), cellulose rete (analyzing film), absorbent material layer are attached to successively from right to left on the supporting layer (base plate) with bonding agent, and are cut into the wide test strips of 3-4cm.
6, the detection reaction principle of immuno-chromatographic test paper strip of the present invention
After test strips test lead inserts testing sample solution, solution to be measured drives the fluorescence antibody in CL to be measured and fluorescence antibody glass fibre cotton to spread to cellulose rete together by syphonic effect, and the final absorbent material layer infiltrating handle end.In diffusion process, CL to be measured can combine with fluorescence antibody, and then the antigen-combining site of CL on closed fluorescence antibody, the detection trace of the CL artificial antigen of fluorescence antibody on cellulose membrane is stoped to be combined, detection trace can not be shown, sheep or rabbit anti-mouse IgG(or goat anti-rabbit igg) antibody then can be combined with fluorescence antibody, under infrared excitation (or using phosphor reader directly to read value) formed red contrast trace band "
︱", namely red zone "
︱" trace is positive expression; Otherwise time in sample solution without CL, then the CL artificial antigen of fluorescence antibody on cellulose membrane can not be stoped to detect trace and to be combined, display red detection trace band "
︱", same goat-anti or rabbit anti-mouse IgG(or goat anti-rabbit igg) antibody is also combined with golden labeling antibody, display red contrast trace band "
︱", formed two red zones "
︱ ︱" be negative expression.If without any red trace band display on cellulose membrane, then show that test strips lost efficacy.
following examples illustrate structure and the detection method of test strips.
Embodiment one: see Fig. 1 and Fig. 2.In figure, 1 is supporting layer, make with plastic slice bar, 2 is adsorbing fiber layer, make with glass fibre cotton, fluorescence antibody fibrage 3 is adsorbed with the fluorescence antibody glass fibre cotton of anti-CL monoclonal antibody, cellulose rete 4 adopts nitrocellulose filter, the absorbent material layer 5 of handle end is made with absorbent filter, adsorbing fiber layer 2, fluorescence antibody fibrage 3, cellulose rete 4, each layer of absorbent material layer 5 are pasted and fixed on successively from right to left on supporting layer 1, intersection fiber crosses one another infiltration each other.Cellulose rete 4 is provided with stealthy detection trace 6, makes with the bovine serum albumin solution (BSA) of coupling CL; Stealthy contrast trace 7 goat anti-mouse igg antibody solution trace on cellulose membrane is made "
︱", two trace bands are arranged in parallel, formation combination trace band "
︱ ︱".
8-1 is the sample end white diaphragm covered above adsorbing fiber layer 2 and fluorescence antibody fibrage 3; 8-2 is other color diaphragm (as yellow) covered above absorbent material layer 5; 9 is sample mark line; this mark line is positioned at the adsorbing fiber layer 2 white diaphragm corresponding with fluorescence antibody fibrage 3 intersection and is partial to adsorbing fiber layer 2 side and is about 0.5cm place, diaphragm is printed on arrow and max printed words on the right side of mark line.
The preparation of testing sample and detecting step:
Detect meat sample: to be shredded by sample, levigate, make the sample suspension of 1:2 ~ 10 with normal saline dilution;
Method of operating: CL test strips sample end inserted in testing sample, insertion depth is no more than mark line, and about 10 ~ 20 seconds took out test strips, observed result under 980nm infrared excitation, or directly read value by phosphor reader.
Result judge: if (a) positive show on cellulose membrane a red trace band "
︱", represent that testing result is positive, illustrate in testing sample containing CL; If (b) feminine gender show on cellulose membrane two red trace bands "
︱ ︱", represent that testing result is negative, illustrate in testing sample not containing CL; On cellulose membrane, do not have red zone to show if c () is lost efficacy, then showed that test strips lost efficacy.
Embodiment two: test strips structure is substantially identical with embodiment one; difference is: fluorescence antibody fibrage 3 is adsorbed with the polyclonal antibody of anti-CL; adsorbing fiber layer 2 is made with nylon membrane; cellulose rete 4 adopts pure cellulose film; the stealthy trace band that detects is " ten " with stealthy contrast trace band, and 8-2 is the blue look diaphragm of handle end covered above absorbent material layer 5.
Detect milk sample: the sample suspension with physiological saline, milk sample dilution being made 1:2 ~ 5.
Result judge: if (a) positive show on cellulose membrane a red trace band "
ten", represent that testing result is positive, illustrate in testing sample containing CL; If (b) feminine gender show on cellulose membrane two red trace bands "
ten", represent that testing result is negative, illustrate in testing sample not containing CL; On cellulose membrane, do not have red zone to show if c () is lost efficacy, then showed that test strips lost efficacy.Method of operating is with embodiment one.
Embodiment three: test strips structure is substantially identical with embodiment one; difference is: adsorbing fiber layer 2 polyvinylidene fluoride pvdf membrane is made; the carrier protein solution of coupling CL is chicken ovalbumin (OVA); stealthy contrast trace 7 rabbit anti-mouse IgG antibody solution is made on cellulose membrane; cellulose rete 4 adopts carboxylated cellulose film; 8-2 is the handle end greenism film covered above absorbent material layer 5, and the stealthy trace band that detects is " ┬ " with stealthy contrast trace band.
For detecting blood sample: extract serum and diluted the testing sample making 1:2 ~ 10 with physiological saline.
Result judgement and method of operating are all with embodiment one.
Embodiment four: test strips structure is substantially identical with embodiment one, and difference is: adsorbing fiber layer 2 is made with polyester film, cellulose rete 4 adopts carboxylated cellulose film, and the stealthy carrier protein solution detecting coupling CL in trace 6 is hemocyanin (KLH).For detecting urine sample, can directly get urine as testing sample.Detect trace band and contrast trace band and be " ┴ ".Method of operating and result decision method are with example one.
Embodiment five: test strips structure is substantially identical with embodiment one, and difference is: stealthy contrast trace 7 goat anti-rabbit igg antibody solution is made on cellulose membrane, and adsorbing fiber layer 2 is made with nylon membrane.Detect trace band and contrast trace band and be " ├ ".Detect sample, result judgement and method of operating with example one.
Embodiment six: substantially identical with embodiment one, difference is: fluorescence antibody fibrage 3 is adsorbed with the polyclonal antibody of anti-CL, detection sample is milk sample.Detect trace band and contrast trace band and be " ┤ ".
Embodiment seven: substantially identical with embodiment one, difference is: fluorescence antibody fibrage 3 is adsorbed with the polyclonal antibody of anti-CL, detection sample is blood sample.
Embodiment eight: substantially identical with embodiment one, difference is: fluorescence antibody fibrage 3 is adsorbed with anti-CL polyclonal antibody, detection sample is urine sample.
Embodiment nine: substantially identical with embodiment one, difference is: in stealthy detection trace 6, coupling CL carrier protein solution is hemocyanin (KLH), detects sample, result judgement and method of operating with embodiment one, does not repeat.
Embodiment ten: substantially identical with embodiment one, difference is: in stealthy detection trace 6, coupling CL carrier protein solution is chicken ovalbumin (OVA), detects sample, result judgement and method of operating with embodiment one, does not repeat.
Embodiment 11: the sensitivity of test strips of the present invention, specific detection
1, the detection of sensitivity: use phosphate buffered solution PBS(PH7.4) or distilled water respectively configuration concentration be 4,2,1,0.5,0.25,0.125,0.0625, the CL standard items of 0ng/mL, loading 80-100uL in test strips of the present invention, react after 5-10 minute, observations under ultraviolet light.
Test strips reacted under ultraviolet light is taken pictures, picture drawing tools is opened, select T line region with the rectangle tool, measure its shading value (L
t), deduct the bias light angle value (L between T line (detection line) and C line (control line)
b), with inhibiting rate L
t-L
bfor ordinate, with the logarithm value of different CL concentration for horizontal ordinate, drawing standard suppresses curve, carries out correlation regression analysis, calculates the IC of this test strips to CL
50and lowest detectable limit.After measured, this test paper to the Regression Equations of CL is: y=-49.952x+131.57, and related coefficient is R
2=0.9929, go out the IC of this test paper to CL according to regression equation calculation
50for 429.50pg/mL, the lowest detection of this test paper is limited to 107.74pg/mL, shows that test paper has higher sensitivity to CL.See Fig. 3.
2, specific detection: using the similar drugs Ractopamine of CL, Cimaterol and daimeton, sulphadiazine, oxolinic acid, penicillin, tetracycline chloromycetin, neomycin, olaquindox as competitor, the concentration configuring above-mentioned mark product is 1mg/mL, with its inhibiting rate of up-conversion fluorescence detection paper, with the IC of this test paper to CL
50with the IC of each competitor
50number percent be its cross reacting rate.
Measurement result sees the following form 1.Can find out, the specificity of this test strips is better, no cross reaction equal to other drug.
| Compound | Half-inhibition concentration IC 50（ng/mL） | Cross reactivity (%) |
| Clenobuterol hydrochloride | 0.43 | 100 |
| Ractopamine | > 1.0×10 3 | < 0.04 |
| Cimaterol | > 1.0×10 3 | < 0.04 |
| Daimeton | > 1.0×10 3 | < 0.04 |
| Sulphadiazine | > 1.0×10 3 | < 0.04 |
| Oxolinic acid | > 1.0×10 3 | < 0.04 |
| Penicillin | > 1.0×10 3 | < 0.04 |
| Tetracycline | > 1.0×10 3 | < 0.04 |
| Chloromycetin | > 1.0×10 3 | < 0.04 |
| Neomycin | > 1.0×10 3 | < 0.04 |
| Olaquindox | > 1.0×10 3 | < 0.04 |
Claims (7)
1. the immuno-chromatographic test paper strip based on the detection Clenbuterol of upper conversion fluorescent nano particle mark, bottom is supporting layer, middle layer is adsorbed layer, protective seam is fixed on adsorbed layer, adsorbed layer is followed successively by the absorbent material layer of adsorbing fiber layer, fluorescence antibody fibrage, cellulose rete and handle end from test lead, it is characterized in that: the stealth be provided with on cellulose rete with the carrier protein solution of coupling CL is printed detects trace, be also provided with the stealth contrast trace printed with goat anti-mouse igg, rabbit anti-mouse IgG or goat anti-rabbit igg antibody solution; Described fluorescence antibody fibrage adopts the glass fibre cotton of absorption fluorescence antibody to make, and fluorescence antibody adopts NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody;
Described NaYF
4: Yb:Er nano particle is with NaYF
4for matrix, Yb
3+for sensitizer, the diameter formed by Yb and Er codope is the nano particle of 50-200nm;
Described NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody are prepared by following methods, and concrete steps are:
(1) surface siliconization of fluorescent nano particle
By NaYF
4: it is in the ethanolic solution of 10% that Yb:Er fluorescent nano particle is dispersed in mass concentration, under agitation adds 5ml strong aqua, and reaction 10min, then adds 2ml tetraethyl orthosilicate, room temperature reaction 3h; The centrifugal 5min of 6000rpm, disperses with ethanol after washing;
(2) surface amination of fluorescent nano particle
The fluorescent nano particle of surface siliconization is added in the mixed solution of methyl alcohol that volume ratio is 3:5, acetone, disperse through ultrasound wave, add N-(2-the aminoethyl)-3-aminopropyl trimethoxysilane of 5 μ l, 70 DEG C of water-bath 1h, the centrifugal 5min of 6000rpm, the precipitation ethanol obtained is washed, dry;
(3) mark of CL antibody
By the NaYF that surface is modified through amination
4: Yb:Er nano particle PBS buffer solution disperses, add the glutaraldehyde solution of mass concentration 25% wherein, room temperature reaction 3 hours, centrifugally wash away unnecessary glutaraldehyde, then be dispersed in PBS buffer solution by reactant liquor, add monoclonal antibody or the polyclonal antibody of CL, 4 DEG C are reacted 3 hours, through centrifuge washing, namely obtain NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody, be placed in PBS buffer solution, 4 DEG C of preservations.
2. immuno-chromatographic test paper strip according to claim 1, is characterized in that: described adsorbing fiber layer glass fibre cotton, nylon membrane, PVDF membrane or polyester film; Absorbent material layer absorbent filter, the supporting layer toughness material do not absorbed water; Cellulose rete nitrocellulose filter, pure cellulose film or carboxylated cellulose film;
the carrier protein of coupling CL is bovine serum albumin(BSA), chicken ovalbumin or hemocyanin.
3. immuno-chromatographic test paper strip according to claim 1, is characterized in that: described stealth detect trace and stealthy contrast trace be arranged in parallel "
︱ ︱" orthoscopic trace, or be " 10 " font arrangement trace, or be " ┬ ┬ " font arrangement trace, or be " ┴ ┴ " font arrangement trace, or be " ├ ├ " font arrangement trace, or be " ┤ ┤ " font arrangement trace.
4. immuno-chromatographic test paper strip according to claim 1; it is characterized in that: on described adsorbing fiber layer, fluorescence antibody fibrage and absorbent material layer, be coated with diaphragm; the diaphragm that adsorbing fiber layer is corresponding with fluorescence antibody fibrage intersection is printed with sample mark line, this mark line deflection adsorbing fiber layer side 0.3-0.7cm.
5. the immuno-chromatographic test paper strip according to any one of claim 1-4, is characterized in that: described NaYF4:Yb:Er nano particle adopts coprecipitation preparation, and concrete grammar is as follows:
Get the Y (NO that concentration is 0.2mol/L respectively
3)
3yb (the NO of 20ml, 0.2mol/L
3)
3er (the NO of 2ml, 0.2mol/L
3)
3the EDTA-Na21ml of 0.5ml, 1mol/L, adds in flask, and 50 DEG C of oil bath stirring reaction 1h, obtain reactant liquor A;
Get the NaF solution of 50ml, 1mol/L, add in polytetrafluoroethylcontainer container, under 50 DEG C of stirred in water bath, reactant liquor A is poured in NaF solution, reaction 1min; The centrifugal 5min of 6000rpm, abandoning supernatant must precipitate; Add water in precipitation, ultrasonic washing 3 times, the centrifugal 5min of 7000rpm; Again by precipitation absolute ethyl alcohol ultrasonic washing 2 times, the centrifugal 5min of 10000rpm, is placed in 80 DEG C of baking oven dried overnight by the solid obtained; Dried solid is put into muffle furnace, in 500 DEG C of calcining 5h, namely obtains NaYF
4: Yb:Er fluorescent nano particle.
6. the immuno-chromatographic test paper strip according to any one of claim 1-4, is characterized in that: described NaYF
4: Yb:Er nano particle adopts hydrothermal synthesis method preparation, and concrete grammar is as follows:
Get the Y (NO that concentration is 0.2mol/L respectively
3)
34ml, Yb (NO
3)
30.5ml, Er (NO
3)
30.1ml, EDTA-Na4ml, mix and fully react, and obtains reactant liquor A; Take NaOH 0.7g, join in the mixed liquor of 8ml oleic acid and 12ml ethanol, mixing, the under agitation slow NaF solution injecting 10mL, 1mol/L in mixed liquor, after filling, continue to be stirred to solution and to be translucent shape; Reactant liquor A is poured in described solution, mixes, ageing 20-30min; Then potpourri is transferred in polytetrafluoroethylcontainer container, 130-150 DEG C of oil bath reaction 12-18h, the product obtained after filtration, washing, dry, namely obtain NaYF
4: Yb:Er fluorescent nano particle.
7. the preparation method of immuno-chromatographic test paper strip described in claim 1, is characterized in that: the method comprises the following steps:
(1) preparation of CL monoclonal antibody or polyclonal antibody;
(2) preparation of fluorescence antibody: first prepare NaYF
4: Yb:Er fluorescent material, described fluorescent material is with NaYF
4for matrix, Yb
3+for sensitizer, formed the nano particle of diameter 50-200nm by Yb and Er codope; Then CL monoclonal antibody or polyclonal antibody are carried out fluorescence labeling;
(3) preparation of adsorbing fiber layer: adsorbing fiber layer glass fibre cotton, nylon membrane, PVDF membrane or polyester film are made;
(4) preparation of cellulose rete: cellulose rete nitrocellulose filter, pure cellulose film or carboxylated cellulose film, with point sample instrument diverse location specking detection trace and contrast trace respectively on cellulose membrane, dries;
(5) assembling of test strips: adsorbing fiber layer, fluorescence antibody fibrage, cellulose rete, absorbent material layer are attached to from right to left successively and scribble on the supporting layer of bonding agent, successively supporting layer, adsorbed layer and protective seam are assembled into test strips;
Described fluorescently-labeled concrete steps are as follows:
(1) surface siliconization of fluorescent nano particle
By NaYF
4: it is in the ethanolic solution of 10% that Yb:Er fluorescent nano particle is dispersed in mass concentration, under agitation adds 5ml strong aqua, and reaction 10min, then adds 2ml tetraethyl orthosilicate, room temperature reaction 3h; The centrifugal 5min of 6000rpm, disperses with ethanol after washing;
(2) surface amination of fluorescent nano particle
The fluorescent nano particle of surface siliconization is added in the mixed solution of methyl alcohol that volume ratio is 3:5, acetone, disperse through ultrasound wave, add N-(2-the aminoethyl)-3-aminopropyl trimethoxysilane of 5 μ l, 70 DEG C of water-bath 1h, the centrifugal 5min of 6000rpm, the precipitation ethanol obtained is washed, dry;
(3) mark of CL antibody
By the NaYF that surface is modified through amination
4: Yb:Er nano particle PBS buffer solution disperses, add the glutaraldehyde solution of mass concentration 25% wherein, room temperature reaction 3 hours, centrifugally wash away unnecessary glutaraldehyde, then be dispersed in PBS buffer solution by reactant liquor, add monoclonal antibody or the polyclonal antibody of CL, 4 DEG C are reacted 3 hours, through centrifuge washing, namely obtain NaYF
4: the CL monoclonal antibody of Yb:Er nanoparticle label or polyclonal antibody, be placed in PBS buffer solution, 4 DEG C of preservations.
?
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210281872.0A CN102798720B (en) | 2012-08-09 | 2012-08-09 | Immune chromatography test paper for quantitative determination of clenbuterol based on up-conversion fluorescent nanoparticle label and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210281872.0A CN102798720B (en) | 2012-08-09 | 2012-08-09 | Immune chromatography test paper for quantitative determination of clenbuterol based on up-conversion fluorescent nanoparticle label and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102798720A CN102798720A (en) | 2012-11-28 |
| CN102798720B true CN102798720B (en) | 2015-01-21 |
Family
ID=47197891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210281872.0A Expired - Fee Related CN102798720B (en) | 2012-08-09 | 2012-08-09 | Immune chromatography test paper for quantitative determination of clenbuterol based on up-conversion fluorescent nanoparticle label and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102798720B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104101708B (en) * | 2013-04-11 | 2016-06-01 | 中国科学院化学研究所 | A kind of immune chromatography test paper based on up-conversion fluorescence/magnetic nanoparticle and its preparation method |
| CN103454423A (en) * | 2013-08-03 | 2013-12-18 | 河南百奥生物工程有限公司 | Up-conversion fluorescence immune chromatography test paper for quantitative detection of neomycin and preparation method thereof |
| CN103869063B (en) * | 2014-03-21 | 2016-03-30 | 合肥工业大学 | The preparation method of strong anti-matrix interference type bisphenol-A up-conversion fluorescence chromatograph test strip |
| CN104374909A (en) * | 2014-11-17 | 2015-02-25 | 北京工业大学 | Chloramphenicol quantitative detection method based on up-conversion phosphor technology and immunochromatography technology |
| CN104818025B (en) * | 2015-03-31 | 2017-05-31 | 渤海大学 | The preparation method of Clenbuterol molecular engram up-conversion luminescent material fluorescence probe |
| CN106018794B (en) * | 2016-06-14 | 2017-08-04 | 焦作百奥泰科生物科技有限公司 | A kind of fluorescence immune chromatography test paper of the detection toxin of T 2 |
| CN105974109B (en) * | 2016-06-14 | 2017-08-04 | 中州大学 | A kind of fluorescence immune chromatography test paper for detecting ochratoxin A |
| CN106066400B (en) * | 2016-06-14 | 2017-11-17 | 焦作百奥泰科生物科技有限公司 | A kind of fluorescence immune chromatography test paper for detecting zearalenone |
| CN111220802B (en) * | 2020-01-19 | 2023-05-02 | 新乡医学院 | Clenbuterol hydrochloride small molecule hapten high sensitivity detection test paper based on nano antibody and preparation method thereof |
| CN116496785B (en) * | 2023-02-06 | 2024-04-26 | 陕西理工大学 | Fe3O4Nano fluorescent probe composited with HAp@Au and preparation method and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1621492A (en) * | 2004-10-26 | 2005-06-01 | 清华大学 | Method for burning synthesis of ytterbium and erbium -codoped conversion luminescent material on sodium yttrium fluoride |
| CN101020824A (en) * | 2007-03-12 | 2007-08-22 | 中国科学院长春应用化学研究所 | Infrared ray excited up-conversion luminescent material and its prepn |
| CN101225304A (en) * | 2007-12-18 | 2008-07-23 | 湘潭大学 | Multi-band fluorescent infrared up-conversion material based on sensitizer substrate |
| CN101551388A (en) * | 2009-05-22 | 2009-10-07 | 上海师范大学 | Immunochromatographic test paper for quantitatively detecting AFP based on up-converting phosphor technology |
| CN201429606Y (en) * | 2009-07-07 | 2010-03-24 | 宁波博奥生物工程有限公司 | Up-converting phosphor detection test paper strip capable of checking clenobuterol hydrochloride quantitatively and rapidly |
| CN102116770A (en) * | 2009-12-31 | 2011-07-06 | 北京热景生物技术有限公司 | Immunochromatography rapid kit and production method thereof |
| CN202814980U (en) * | 2012-08-09 | 2013-03-20 | 河南省农业科学院 | Immuno-chromatographic test strip for quantitative detection of clenbuterol based on up-conversion fluorescence nano-particle marks |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1690711B (en) * | 2004-04-23 | 2010-04-14 | 中国人民解放军军事医学科学院微生物流行病研究所 | Immune chromatographic test paper bar based on up conversion luminescence technology |
| CN101966978A (en) * | 2010-10-09 | 2011-02-09 | 吉林大学 | Method for preparing multi-metal-oxygen cluster-doped silicon dioxide nanoparticles |
-
2012
- 2012-08-09 CN CN201210281872.0A patent/CN102798720B/en not_active Expired - Fee Related
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1621492A (en) * | 2004-10-26 | 2005-06-01 | 清华大学 | Method for burning synthesis of ytterbium and erbium -codoped conversion luminescent material on sodium yttrium fluoride |
| CN101020824A (en) * | 2007-03-12 | 2007-08-22 | 中国科学院长春应用化学研究所 | Infrared ray excited up-conversion luminescent material and its prepn |
| CN101225304A (en) * | 2007-12-18 | 2008-07-23 | 湘潭大学 | Multi-band fluorescent infrared up-conversion material based on sensitizer substrate |
| CN101551388A (en) * | 2009-05-22 | 2009-10-07 | 上海师范大学 | Immunochromatographic test paper for quantitatively detecting AFP based on up-converting phosphor technology |
| CN201429606Y (en) * | 2009-07-07 | 2010-03-24 | 宁波博奥生物工程有限公司 | Up-converting phosphor detection test paper strip capable of checking clenobuterol hydrochloride quantitatively and rapidly |
| CN102116770A (en) * | 2009-12-31 | 2011-07-06 | 北京热景生物技术有限公司 | Immunochromatography rapid kit and production method thereof |
| CN202814980U (en) * | 2012-08-09 | 2013-03-20 | 河南省农业科学院 | Immuno-chromatographic test strip for quantitative detection of clenbuterol based on up-conversion fluorescence nano-particle marks |
Non-Patent Citations (5)
| Title |
|---|
| Detection of Analytes by Immunoassay Using Up-Converting Phosphor Technology;R. Sam Niedbala,et al.;《Analytical Biochemistry》;20010601;第293卷(第1期);第22-30页 * |
| NaYF4∶Yb,Er/Tm上转换荧光纳米材料的合成、修饰及应用;王猛 等;《化学进展》;20081231;第20卷(第12期);第1180-1185页 * |
| Uniform Nanostructured Arrays of Sodium Rare-Earth Fluorides for Highly Efficient Multicolor Upconversion Luminescence;Fan Zhang，et al.;《Angewandte Chemie International Eidition》;20071022;第46卷(第42期);第7977页，附加材料"Experimental Section"部分 * |
| 王猛 等.NaYF4:Yb,Er上转换荧光纳米颗粒的共沉淀法合成及表征.《光谱学与光谱分析》.2009,第29卷(第12期),3327-3331. * |
| 郑琦 等.稀土上转换发光材料NaYF4:Yb:Er的合成研究.《化工技术与开发》.2007,第36卷(第6期),第1-3、6页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102798720A (en) | 2012-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102798720B (en) | Immune chromatography test paper for quantitative determination of clenbuterol based on up-conversion fluorescent nanoparticle label and preparation method thereof | |
| CN202814980U (en) | Immuno-chromatographic test strip for quantitative detection of clenbuterol based on up-conversion fluorescence nano-particle marks | |
| CN102866252B (en) | Immunochromatography test strip marked by phosphorescent silica nano particles and used for quantitatively detecting cimaterol and preparation method for immunochromatography test strip | |
| CN103454423A (en) | Up-conversion fluorescence immune chromatography test paper for quantitative detection of neomycin and preparation method thereof | |
| CN102798719B (en) | Test paper strip for rapidly detecting traces of chlorothalonil and preparation method thereof | |
| CN103018452B (en) | A kind of colloidal gold test paper card and detection method detecting salbutamol medicine | |
| CN206725442U (en) | A kind of paper chip for being used to detect CLE, RAC and SBL simultaneously | |
| CN101434655B (en) | Preparation of egg yolk antibody against citrinin | |
| CN107941785A (en) | A kind of surface-enhanced Raman gold label test strip for quickly detecting micro ethiprole and preparation method thereof | |
| CN100488983C (en) | Technology for preparing colorless malachite green complete antigen and monoclonal antibody | |
| CN105974109B (en) | A kind of fluorescence immune chromatography test paper for detecting ochratoxin A | |
| CN105334323A (en) | Method and test strip for detecting zilpaterol, and application of test strip | |
| CN101408545A (en) | Melamine fast detecting test paper bar and test paper card | |
| CN103439489B (en) | Fluorescent silica labeled immunochromatographic test paper for quantitative gentamicin detection and preparation method | |
| CN104610079B (en) | A kind of salbutamol hapten derivant, salbutamol artificial antigen and its preparation method and application | |
| CN106018795B (en) | A kind of fluorescence immune chromatography test paper for detecting aflatoxin B1 | |
| CN105004863A (en) | Colloidal gold immunochromatography test paper for rapidly detecting soybean sensitizing protein beta-conglycinin, and production method thereof | |
| CN108226514A (en) | A kind of newcastle disease virus antibody rapid quantitative detection reagent box and its application | |
| CN106896094A (en) | It is a kind of at the same detect CLE, RAC and SBL method and its special paper chip | |
| CN201514410U (en) | Food-borne terramycin residual quick semi-quantitative detection indicator paper strip and indicator paper card | |
| CN103454420B (en) | Test strip for rapidly detecting trace sulfachlorpyridazine and preparation method thereof | |
| CN2653511Y (en) | Kelunteluo fast semi quantitative detection test paper | |
| CN103163296A (en) | Immune colloidal gold test strip for detection of ractopamine residue in swine urine | |
| CN203037658U (en) | Phosphorescent silicon dioxide nanoparticle labeled immunochromatographic test strip for quantitatively detecting cimaterol | |
| CN104914248A (en) | Colloidal gold immunochromatographic test paper capable of quickly detecting SBA (Soybean Agglutinin) and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150121 |